Larimar Therapeutics Inc. (LRMR)
1.91
-0.07 (-3.54%)
At close: Apr 04, 2025, 1:54 PM
Larimar Therapeutics Ratios Statement
Financials in USD. Fiscal year
is
January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 |
Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 |
-2.94 | -5.41 | -3.11 | -3.68 | -6.01 | -5.31 | -2.6 | -2.44 | -1.5 | -2.27 | -24.45 | -36.8 | -37.19 | -39.23 | |
-0.05 | 0.15 | 0.06 | 0.21 | -0.14 | 0.06 | -6.57 | 0.23 | 0.06 | -0.02 | -0.19 | -16.82 | -6.84 | n/a | |
n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | |
1.38 | 2.44 | 0.96 | 2.88 | 2.84 | -176.84 | 1.71 | 1.62 | 0.71 | 1.00 | 8.56 | 14.65 | 64.07 | n/a | |
-3.33 | -5.94 | -3.85 | -4.36 | -6.02 | -5.39 | -3.09 | -2.89 | -1.65 | -2.8 | -31.6 | -34.36 | -37.98 | -41.93 | |
-3.35 | -5.97 | -3.86 | -4.4 | -6.03 | -5.41 | -3.1 | -2.89 | -1.67 | -2.83 | -31.66 | -34.4 | -37.98 | -42.05 | |
n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | |
0.03 | 0.07 | 0.05 | 0.09 | 0.07 | -0.14 | 0.22 | 0.26 | 0.03 | 0.04 | 0.07 | n/a | n/a | n/a | |
8.02 | 9.49 | 11.28 | 8.19 | 10.90 | 0.27 | 9.12 | 14.39 | 13.23 | 11.37 | 16.98 | 12.82 | 3.52 | n/a | |
8.02 | 9.49 | 11.28 | 8.16 | 10.89 | 0.81 | 9.12 | 14.39 | 13.23 | 11.37 | 16.98 | 12.82 | 3.52 | n/a | |
n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | |
n/a | n/a | n/a | n/a | n/a | n/a | n/a | -55.48 | -164.62 | -91.58 | 40.84 | n/a | -142.18 | n/a | |
n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | |
n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | |
n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | |
n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | |
n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | |
n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | |
n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | |
n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | |
n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | |
n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | |
n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |